6 Warning Signs You Have An Enlarged Prostate

Article Summary
- Benign Prostatic Hyperplasia (BPH) occurs when the prostate expands to twice or even three times its regular size.
- As a result, the growing prostate gland gradually presses against the urethra, restricting urinary flow.
- This can cause several urinary symptoms, such as frequent and painful urination, blood in the urine and urinary retention.
Most men over 50 notice changes in how they urinate and chalk it up to getting older. Sometimes that’s fair. But the 6 warning signs you have an enlarged prostate are specific enough that ignoring them isn’t a great idea, catching them early makes a genuine difference to your long-term bladder health.
What Is an Enlarged Prostate and Why Does It Affect Urination?
Benign prostatic hyperplasia (BPH) is a non-cancerous growth of the prostate gland that develops as men age. The prostate sits directly below the bladder and wraps around the urethra, the tube that carries urine out of the body. When prostate tissue expands, it squeezes the urethra and restricts urine flow; that compression is the root cause of most urinary symptoms men experience.
BPH is far more common than most men expect. According to a 2025 analysis published in BMC Urology, global BPH cases grew by 122% between 1990 and 2021. The NIDDK reports that 29% to 33% of men 65+ affected by BPH, with histological studies showing 80% to 90% of men over 70 have BPH at autopsy. Symptoms typically show up in the 50s, though some men notice changes even before that.
Understanding the full picture of prostate gland function helps clarify why compression produces such distinct urinary problems. A detailed overview of BPH signs and causes, along with current BPH statistics by age, rounds out the context.
The 6 Most Common Warning Signs of an Enlarged Prostate
Every one of the 6 warning signs you have an enlarged prostate traces back to a single source: the compressed urethra disrupting normal urine flow. Some symptoms involve getting urine started; others are about how it flows once you do; some are about what’s left behind afterward. Lower urinary tract symptoms is the clinical umbrella term, and BPH is the most common cause in men over 50.
Urgency and frequency often travel together, but they’re distinct. Urgency is a sudden, hard-to-ignore urge; frequency is simply how often you go. Hesitancy and incomplete emptying are also separate symptoms, each rooted in a slightly different mechanism. According to Houston Methodist’s clinical guidance, more than half of men over 60 will notice at least one of these signs, and the same 2025 BPH burden study links higher symptom burden directly to reduced quality of life.
Frequent Urination, Especially at Night
Needing to urinate more than eight times during the day, or waking more than once at night, is a recognized clinical signal worth raising with your doctor. The nighttime version has its own name: nocturia. Waking twice or more to urinate is the threshold most urologists use to flag a potential prostate problem. And nocturia is often the first symptom men actually notice, because disrupted sleep is hard to explain away.
Weak or Interrupted Urine Stream
A stream that’s noticeably weaker than it used to be, or one that stops and starts mid-flow, points to obstruction at the urethra. Prostate tissue squeezing inward reduces pressure and slows output; men often describe straining or pushing just to keep things moving. If you’ve noticed a weak urine stream developing gradually over months, that slow trajectory matters as much as the severity itself.
Difficulty Starting or Stopping Urination
Hesitancy means standing at the toilet and waiting, sometimes 30 seconds or longer, before urine begins to flow. It happens because the compressed urethra creates resistance the bladder muscles have to work against. Stopping flow on purpose can feel equally difficult.
This is mechanically different from incomplete emptying. Hesitancy is about initiating flow; incomplete emptying is about what remains in the bladder afterward. Both are warning signs, but they reflect different stages of the same underlying obstruction.
Urgent Need to Urinate
Urgency is that sudden, sharp sensation that you need to go right now. It’s not a gentle nudge toward finding a bathroom; it’s strong enough to interrupt whatever you’re doing. The bladder grows increasingly sensitive as it works harder against the obstruction, which lowers its threshold for triggering the urge signal.
Incomplete Bladder Emptying
After urinating, you might walk away with the nagging sense that you didn’t quite finish. That feeling is often accurate. Post-void residual urine, the amount left in the bladder after you void, builds up over time as the obstruction worsens. It’s different from hesitancy (difficulty starting) and distinct from post-void dribbling (a few drops that escape once you’re done).
Dribbling After Urination
Post-void dribbling is exactly what it sounds like: a few drops of urine that leak out after you think you’re finished, often as you’re adjusting clothing. This is a post-void symptom, not an inability to urinate. That distinction matters, urinary retention, the complete inability to empty the bladder, is a medical emergency and an entirely different, more serious condition.
What’s Actually Happening When Your Prostate Enlarges
As testosterone levels shift with age, a related hormone called dihydrotestosterone (DHT) accumulates in prostate cells and drives tissue growth. The prostate expands inward, compressing the prostatic urethra from all sides. A 2025 Scientific Reports analysis of GBD data found a 122% global rise in BPH cases since 1990, driven primarily by an aging global population.
The urinary tract’s relationship to prostate health is worth understanding because the urethra’s path through the gland is what makes prostate enlargement so directly symptomatic. Research on intravesical prostatic protrusion shows that the direction and degree of prostate growth affects which symptoms end up most pronounced. Men with obesity, type 2 diabetes and BPH risk that comes with metabolic syndrome also tend to develop BPH earlier and with greater severity. A doctor may use a digital rectal exam to get an initial read on prostate size.
Why These Symptoms Get Worse Over Time
BPH doesn’t typically reverse on its own. The prostate grows at roughly 2% to 2.5% per year in older men, and symptoms intensify as it does. A GBD 2019 systematic analysis confirmed that untreated BPH leads to a measurable rise in complications over time.
Here’s the thing, left unmanaged, bladder outlet obstruction can cause the bladder wall to thicken and weaken, reducing its ability to contract effectively. That’s a largely irreversible change. Untreated BPH can also lead to bladder stones, urinary tract infections, hematuria (blood in the urine), and kidney damage. Urinary retention, the sudden, complete inability to pass urine, is a urological emergency requiring immediate catheterization. Bladder infections follow incomplete emptying because stagnant urine is a breeding ground for bacteria; early intervention genuinely matters. According to Cleveland Clinic’s clinical guidance, catching BPH early preserves bladder function that becomes harder to restore the longer the obstruction persists.
Persistent urinary urgency that doesn’t respond to lifestyle changes is one of the clearest signals that symptoms are progressing.
When to See a Doctor About Prostate Symptoms
See a doctor promptly if you can’t urinate at all, notice blood in your urine, feel pain in your lower abdomen or pelvis, or develop a fever alongside urinary symptoms. These can signal an infection or acute urinary retention, both of which need same-day attention.
For milder symptoms, a reasonable rule of thumb: if your urinary pattern has shifted noticeably over the past few months, it’s worth getting checked. The International Prostate Symptom Score (IPSS) is a validated questionnaire your doctor may use to score symptom severity, scores of 8 or above suggest moderate BPH warranting active monitoring. A 2025 epidemiology study published in Translational Andrology and Urology estimated a 26.2% lifetime prevalence of BPH, making it one of the most frequently evaluated conditions in urology. The Medscape BPH overview confirms IPSS-guided assessment as the clinical standard. Urologic disease is worth understanding broadly, since BPH symptoms can overlap with other conditions.
What to Expect at Your Doctor’s Visit
Your doctor will likely start with a medical history and a physical exam, including a digital rectal exam to assess prostate size and texture. A PSA (prostate-specific antigen) blood test helps distinguish BPH from prostate cancer, though elevated PSA can have multiple causes. A urinalysis rules out infection or blood in the urine. Some doctors also order a urinary flow rate test (you urinate into a device that measures stream speed) or an ultrasound to measure post-void residual volume.
A 2017 systematic review in Scientific Reports covering BPH prevalence across 25 countries shows how routinely these evaluations are needed. An epidemiology review on PMC further notes that flow rate testing adds meaningful clinical data. If you’ve noticed difficulty urinating building gradually, documenting when it started gives your doctor a clearer picture of how quickly things are progressing.
Treatment Options Your Doctor May Discuss
BPH treatment follows a stepped approach based on symptom severity. Watchful waiting suits men with mild symptoms (IPSS below 8), paired with lifestyle changes like reducing evening fluid intake and cutting out bladder irritants. Caffeine and alcohol as a bladder irritant are among the most commonly reported triggers that worsen urgency and frequency, making them worth limiting early in any management plan. Medications come next: alpha blockers relax the smooth muscle around the urethra for faster symptom relief, while 5-alpha-reductase inhibitors shrink prostate size over several months but may affect sexual function. Your doctor will weigh both benefits and side effects with you.
For moderate-to-severe cases, minimally invasive procedures are a growing option. A 2025 FDA-cleared intraluminal stent device represents the kind of office-based intervention now available as an alternative to surgery. A current clinical trial on combination pharmacotherapy is studying solifenacin plus tamsulosin for men dealing with both storage and voiding symptoms. Surgical options like TURP remain standard for severe obstruction. The BPH treatment market reached $13.0 billion in 2025, projected to reach $22.59 billion by 2035, which reflects rapid growth across both device-based and pharmacological options.
Some men also explore complementary approaches alongside medical care. Certain plant-based compounds and herbs studied for prostate health have been researched for their potential to support normal urinary function, and natural tips for bladder health may fit well within a broader care plan. These aren’t substitutes for medical treatment, and any supplement should be discussed with your doctor given possible herb-drug interactions. Poor cardiovascular health and prostate function are more closely linked than many men realize, since impaired blood flow to pelvic tissues can accelerate BPH progression alongside other risk factors.
Frequently Asked Questions
How is an enlarged prostate different from prostate cancer?
BPH and prostate cancer are entirely separate conditions. BPH is a non-cancerous overgrowth of prostate tissue and doesn’t increase your cancer risk on its own. Prostate cancer can cause some similar urinary symptoms, which is why a PSA test, and possibly a biopsy, is used to distinguish between them. Your doctor can clarify which diagnosis fits your findings.
Are there lifestyle changes that can help manage prostate symptoms?
Yes, several. Reducing fluid intake in the evenings, cutting back on caffeine and alcohol, and avoiding long periods of sitting can each ease symptoms noticeably. Pelvic floor exercises help some men improve bladder control. These changes work best for mild symptoms and are typically recommended alongside medical management.
Can certain foods or drinks make enlarged prostate symptoms worse?
Caffeine, alcohol, spicy foods, and carbonated drinks are common triggers that irritate the bladder and worsen urgency and frequency. Some men find that cold weather makes things noticeably worse too. Keeping a simple diary of what you eat and drink, and how symptoms shift, gives your doctor genuinely useful information.
Conclusion
The 6 warning signs you have an enlarged prostate (frequent urination, nocturia, a weak stream, hesitancy, urgency, incomplete emptying, and post-void dribbling) are clear enough to act on and common enough that you shouldn’t feel embarrassed bringing them up. BPH is manageable, especially when it’s caught before the bladder sustains lasting damage. This article is informational and isn’t a substitute for medical advice; if any of these symptoms sound familiar, schedule a visit with your doctor.
This article is for informational purposes only and does not serve as medical advice. The details provided here are not a replacement for, and should never be depended upon as, professional medical advice. Always consult your physician regarding the potential risks and benefits of any treatment.
Dr. Howard Tay
MD, FACS, Board-Certified Urologist
Dr. Howard Tay, MD, FACS, is a board-certified urologist in Arizona with 25+ years of experience, recognized as a “Top Doc” by Phoenix Magazine.
Our Medical Review Process
At Ben’s Natural Health, we are committed to maintaining the highest standards of accuracy, transparency, and scientific integrity. Every piece of content is carefully developed by medical professionals and undergoes a thorough review every 12 to 24 months. This ensures that our information remains current, reliable, and rooted in credible, evidence-based research. We reference only peer-reviewed studies from reputable medical journals, providing full citations and direct links to enhance trust and confidence. Learn more about our medical review process and research standards.
Our Editorial Guidelines
For over 25 years, Ben’s Natural Health has been a trusted source of scientifically backed, reliable health information. Our editorial guidelines uphold the highest quality and integrity for every article we publish. Each piece is written by qualified experts and undergoes independent quality checks. We prioritize transparency by clearly displaying contributor credentials and biographies at the beginning of every article. Read more about our editorial standards.
Medical Disclaimer
The content on this blog is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. While our articles are authored and reviewed by licensed medical professionals, they may not address your specific health concerns. Always consult a qualified healthcare provider before making any medical decisions.
Article Sources
- Wei H, Zhu C, Huang Q, Yang J, Li YT, Zhang YG, et al. (2025). Global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021 and projection to 2035. BMC urology, 25(1), 34. https://doi.org/10.1186/s12894-025-01715-9
- Enlarged Prostate (Benign Prostatic Hyperplasia) – NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/urologic-diseases/prostate-problems/enlarged-prostate-benign-prostatic-hyperplasia
- Michael Ng, Stephen W. Leslie, & Krishna M. Baradhi (2024). Benign Prostatic Hyperplasia. https://www.ncbi.nlm.nih.gov/books/NBK558920/
- What Are the Warning Signs of Enlarged Prostate?. houstonmethodist.org. https://www.houstonmethodist.org/blog/articles/2024/feb/what-are-the-warning-signs-of-enlarged-prostate/
- Chen, Xin, Yang, Siyuan, He, Zhangxin, Chen, Zihao, Tang, Xinling, Lin, Yuxin, et al. (2025). Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021. Scientific Reports, 15(1), 5644. https://doi.org/10.1038/s41598-025-90229-3
- Al Rashed AA, Isa QM, Mahdi A, Ebrahim M, Abdulaziz K, Hasan O, et al. (2024). Clinical Outcomes of Intravesical Prostatic Protrusion in Patients With Benign Prostatic Hyperplasia. Cureus, 16(1), e52541. https://doi.org/10.7759/cureus.52541
- GBD 2019 Benign Prostatic Hyperplasia Collaborators (2022). The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The lancet. Healthy longevity, 3(11), e754-e776. https://doi.org/10.1016/S2666-7568(22)00213-6
- Benign Prostatic Hyperplasia (BPH): Symptoms & Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/9100-benign-prostatic-hyperplasia
- Qizhou Mo, Fengyi Wang, Haiqi Liang, Yujian Li, Min Qin, & Jiwen Cheng (2025). Tracking and analysis of benign prostatic hyperplasia and prostate cancer burden globally: 1990–2021 epidemiological trends. Translational Andrology and Urology, 14(3), 76478-76778. https://doi.org/10.21037/tau-2025-12
- Benign Prostatic Hyperplasia (BPH): Practice Essentials, Background, Anatomy. emedicine.medscape.com. https://emedicine.medscape.com/article/437359-overview
- Lee, Shaun Wen Huey, Chan, Esther Mei Ching, & Lai, Yin Key (2017). The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Scientific Reports, 7(1), 7984. https://doi.org/10.1038/s41598-017-06628-8
- Kok Bin Lim (2017). Epidemiology of clinical benign prostatic hyperplasia. Asian Journal of Urology, 4(3), 148. https://doi.org/10.1016/j.ajur.2017.06.004
- https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12357479
- Elpen Pharmaceutical Co. Inc.. (2024). Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin (NCT06528613). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06528613
- Benign Prostatic Hyperplasia Treatment Market Size 2034. imarcgroup.com. https://www.imarcgroup.com/benign-prostatic-hyperplasia-treatment-market
- Benign Prostatic Hyperplasia Treatment Market Set to Reach USD 22.59 Billion by 2035 Amid Rising Adoption of Minimally Invasive Urology Procedures. GlobeNewswire News Room. https://www.globenewswire.com/news-release/2026/05/20/3298458/0/en/Benign-Prostatic-Hyperplasia-Treatment-Market-Set-to-Reach-USD-22-59-Billion-by-2035-Amid-Rising-Adoption-of-Minimally-Invasive-Urology-Procedures-SNS-Insider.html
Article Update History
Reviewer:
Created on January 1, 2022
Explore More

Prostatitis Statistics: Key Facts and Insights in 2026
Prostatitis, an inflammatory condition of the prostate gland, remains a key health concern worldwide. In 2026, a deeper understanding of its prevalence, types, diagnosis, ...